Literature DB >> 30661067

Incidence of Epilepsy after Neonatal Seizures: A Population-Based Study.

Anna Andreolli1, Emanuela Claudia Turco2, Giuseppe Pedrazzi3, Ettore Beghi4, Francesco Pisani5,2.   

Abstract

BACKGROUND: The incidence of childhood and adolescence epilepsy varies in different areas and over time. Published reports in the Italian pediatric population are few and there is no information on the incidence of epilepsy using the new clinical definition of the disease signed by the International League Against Epilepsy. An increased risk of epilepsy is reported in subjects who presented with neonatal seizures (NS), but few population-based studies are available that compare incidence and age at onset of epilepsy in children with and without NS.
OBJECTIVES: Ascertain the incidence of epilepsy in children in the province of Parma by applying the new practical clinical definition of epilepsy, and compare incidence and age of epilepsy onset in children with and without previous NS.
METHODS: The study was carried out in the province of Parma, Emilia-Romagna Region, Northern Italy, using different data sources (clinical records and administrative data), and considered all the children born in the province of Parma between January 2002 and December 2014 and developing epilepsy by December 2016. We calculated the incidence of epilepsy in patients up to 14 years of age, incidence of epilepsy after NS and cumulative incidence of epilepsy at 1, 5, and 10 years' follow-up. To evaluate age at onset of epilepsy, we divided patients into 3 groups (epilepsy onset within 1 month, between 1 and 12 months, and after 1 year of life) and we compared age at onset of epilepsy between patients who had had previous NS and those who had not.
RESULTS: The incidence of epilepsy was 78.6/100,000 persons-years (boys 88.1/100,000, girls 68.6/100,000). The incidence of epilepsy after NS was 15.2% (8.2% for male, 23.5% for female; 16.3% in born at term, 14.3% in pre-term). The incidence of epilepsy at 1, 5, and 10 years' follow-up was higher in patients with previous NS than in others. The age at onset of epilepsy was significantly different in the 2 groups, and was younger in those with history of NS: mean age at onset was 10.5 months in those with NS and of 61.8 months in the others.
CONCLUSIONS: The incidence rate of epilepsy in the Parma district was higher than that reported in other Italian areas studied, probably due to the different methodology used and the application of the most recent definition of epilepsy. Children with NS were at higher risk of epilepsy and develop the disease at a younger age.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Epilepsy; Incidence of epilepsy; Neonatal seizures; Post-neonatal epilepsy

Year:  2019        PMID: 30661067     DOI: 10.1159/000494702

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  5 in total

1.  Effectiveness and adverse drug reactions of levetiracetam and midazolam in refractory neonatal seizure: A cross-sectional comparative study.

Authors:  Diptiman Jayswal; Uttam Kumar Roy; Taraknath Ghosh; Purnendu Mandal
Journal:  J Educ Health Promot       Date:  2021-03-31

Review 2.  Neuromonitoring in Neonatal-Onset Epileptic Encephalopathies.

Authors:  Regina Trollmann
Journal:  Front Neurol       Date:  2021-02-02       Impact factor: 4.003

3.  Quercetin Administration Following Hypoxia-Induced Neonatal Brain Damage Attenuates Later-Life Seizure Susceptibility and Anxiety-Related Behavior: Modulating Inflammatory Response.

Authors:  Yan Wu; Huiping Wei; Pei Li; Hui Zhao; Ruifang Li; Feiyun Yang
Journal:  Front Pediatr       Date:  2022-02-11       Impact factor: 3.418

4.  Neonatal seizures: diagnostic updates based on new definition and classification.

Authors:  Eun-Hee Kim; Jeongmin Shin; Byoung Kook Lee
Journal:  Clin Exp Pediatr       Date:  2022-04-04

Review 5.  Neonatal Seizures-Perspective in Low-and Middle-Income Countries.

Authors:  Hemadri Vegda; Vaisakh Krishnan; Gabriel Variane; Vaishnavi Bagayi; Phoebe Ivain; Ronit M Pressler
Journal:  Indian J Pediatr       Date:  2022-01-20       Impact factor: 1.967

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.